EP0534963A1 - Analyse immunologique pour detecter et determiner l'antigene de pseudocercosporellose dans les cereales - Google Patents
Analyse immunologique pour detecter et determiner l'antigene de pseudocercosporellose dans les cerealesInfo
- Publication number
- EP0534963A1 EP0534963A1 EP19900914368 EP90914368A EP0534963A1 EP 0534963 A1 EP0534963 A1 EP 0534963A1 EP 19900914368 EP19900914368 EP 19900914368 EP 90914368 A EP90914368 A EP 90914368A EP 0534963 A1 EP0534963 A1 EP 0534963A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- antigen
- pseudocercosporella
- antibody
- enzyme
- fungal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 108091007433 antigens Proteins 0.000 title claims abstract description 164
- 102000036639 antigens Human genes 0.000 title claims abstract description 164
- 239000000427 antigen Substances 0.000 title claims abstract description 163
- 238000003018 immunoassay Methods 0.000 title claims abstract description 43
- 235000013339 cereals Nutrition 0.000 title claims abstract description 16
- 241000682843 Pseudocercosporella Species 0.000 title claims description 46
- 238000000227 grinding Methods 0.000 claims abstract description 74
- 230000002538 fungal effect Effects 0.000 claims abstract description 55
- 239000003153 chemical reaction reagent Substances 0.000 claims abstract description 27
- 208000015181 infectious disease Diseases 0.000 claims abstract description 3
- 241001668536 Oculimacula yallundae Species 0.000 claims abstract 3
- 238000000034 method Methods 0.000 claims description 63
- 239000007787 solid Substances 0.000 claims description 35
- 102000004190 Enzymes Human genes 0.000 claims description 29
- 108090000790 Enzymes Proteins 0.000 claims description 29
- 239000000463 material Substances 0.000 claims description 25
- 238000002360 preparation method Methods 0.000 claims description 24
- 230000007246 mechanism Effects 0.000 claims description 22
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 21
- 239000012528 membrane Substances 0.000 claims description 20
- 238000000605 extraction Methods 0.000 claims description 18
- 239000002953 phosphate buffered saline Substances 0.000 claims description 18
- 239000000126 substance Substances 0.000 claims description 18
- 239000012736 aqueous medium Substances 0.000 claims description 15
- 239000000243 solution Substances 0.000 claims description 15
- 239000011536 extraction buffer Substances 0.000 claims description 14
- 239000000758 substrate Substances 0.000 claims description 13
- 241000233866 Fungi Species 0.000 claims description 12
- 238000006243 chemical reaction Methods 0.000 claims description 11
- 150000004676 glycans Chemical class 0.000 claims description 11
- 229920001282 polysaccharide Polymers 0.000 claims description 11
- 239000005017 polysaccharide Substances 0.000 claims description 11
- 102000004169 proteins and genes Human genes 0.000 claims description 11
- 108090000623 proteins and genes Proteins 0.000 claims description 11
- 229920001213 Polysorbate 20 Polymers 0.000 claims description 10
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N biotin Natural products N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 10
- 229960002685 biotin Drugs 0.000 claims description 10
- 239000011616 biotin Substances 0.000 claims description 10
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 claims description 10
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 claims description 10
- VXIVSQZSERGHQP-UHFFFAOYSA-N chloroacetamide Chemical compound NC(=O)CCl VXIVSQZSERGHQP-UHFFFAOYSA-N 0.000 claims description 8
- -1 exoantigen Substances 0.000 claims description 8
- XZKIHKMTEMTJQX-UHFFFAOYSA-N 4-Nitrophenyl Phosphate Chemical group OP(O)(=O)OC1=CC=C([N+]([O-])=O)C=C1 XZKIHKMTEMTJQX-UHFFFAOYSA-N 0.000 claims description 6
- 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 claims description 6
- 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 claims description 6
- 150000001540 azides Chemical class 0.000 claims description 6
- 235000020958 biotin Nutrition 0.000 claims description 6
- 230000002708 enhancing effect Effects 0.000 claims description 6
- 102000002260 Alkaline Phosphatase Human genes 0.000 claims description 5
- 108020004774 Alkaline Phosphatase Proteins 0.000 claims description 5
- 239000004793 Polystyrene Substances 0.000 claims description 5
- 230000008859 change Effects 0.000 claims description 5
- 229920002223 polystyrene Polymers 0.000 claims description 5
- 238000012360 testing method Methods 0.000 claims description 5
- 239000005712 elicitor Substances 0.000 claims description 4
- 102000039446 nucleic acids Human genes 0.000 claims description 4
- 108020004707 nucleic acids Proteins 0.000 claims description 4
- 150000007523 nucleic acids Chemical class 0.000 claims description 4
- 230000000295 complement effect Effects 0.000 claims description 3
- 230000001086 cytosolic effect Effects 0.000 claims description 3
- 239000003053 toxin Substances 0.000 claims description 3
- 231100000765 toxin Toxicity 0.000 claims description 3
- 108700012359 toxins Proteins 0.000 claims description 3
- 239000011324 bead Substances 0.000 claims description 2
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 claims description 2
- 239000006249 magnetic particle Substances 0.000 claims description 2
- 239000002245 particle Substances 0.000 claims description 2
- 239000003656 tris buffered saline Substances 0.000 claims 5
- QRXMUCSWCMTJGU-UHFFFAOYSA-L (5-bromo-4-chloro-1h-indol-3-yl) phosphate Chemical compound C1=C(Br)C(Cl)=C2C(OP([O-])(=O)[O-])=CNC2=C1 QRXMUCSWCMTJGU-UHFFFAOYSA-L 0.000 claims 3
- 201000010099 disease Diseases 0.000 abstract description 15
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 15
- 238000011161 development Methods 0.000 abstract description 8
- 238000001514 detection method Methods 0.000 abstract description 7
- 239000007788 liquid Substances 0.000 abstract description 3
- 238000004458 analytical method Methods 0.000 abstract 1
- 241000196324 Embryophyta Species 0.000 description 46
- 238000003556 assay Methods 0.000 description 40
- 210000001519 tissue Anatomy 0.000 description 23
- 241000209140 Triticum Species 0.000 description 19
- 235000021307 Triticum Nutrition 0.000 description 16
- 230000035945 sensitivity Effects 0.000 description 15
- 239000011159 matrix material Substances 0.000 description 14
- 229920000936 Agarose Polymers 0.000 description 12
- 241001465754 Metazoa Species 0.000 description 12
- 239000000872 buffer Substances 0.000 description 12
- 239000000054 fungal extract Substances 0.000 description 11
- 238000011534 incubation Methods 0.000 description 11
- 239000011780 sodium chloride Substances 0.000 description 11
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 10
- 229920000136 polysorbate Polymers 0.000 description 10
- 239000002585 base Substances 0.000 description 9
- 239000000499 gel Substances 0.000 description 9
- 241000283973 Oryctolagus cuniculus Species 0.000 description 8
- 238000007792 addition Methods 0.000 description 8
- 230000002163 immunogen Effects 0.000 description 8
- 108060003951 Immunoglobulin Proteins 0.000 description 7
- 241000776989 Phaeosphaeria herpotrichoides Species 0.000 description 7
- 102000018358 immunoglobulin Human genes 0.000 description 7
- 208000024891 symptom Diseases 0.000 description 7
- 241000223218 Fusarium Species 0.000 description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 6
- 239000003431 cross linking reagent Substances 0.000 description 6
- 239000000284 extract Substances 0.000 description 6
- 125000000524 functional group Chemical group 0.000 description 6
- 239000000417 fungicide Substances 0.000 description 6
- 239000000419 plant extract Substances 0.000 description 6
- 239000007790 solid phase Substances 0.000 description 6
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 6
- UHPMCKVQTMMPCG-UHFFFAOYSA-N 5,8-dihydroxy-2-methoxy-6-methyl-7-(2-oxopropyl)naphthalene-1,4-dione Chemical compound CC1=C(CC(C)=O)C(O)=C2C(=O)C(OC)=CC(=O)C2=C1O UHPMCKVQTMMPCG-UHFFFAOYSA-N 0.000 description 5
- 241000699670 Mus sp. Species 0.000 description 5
- 239000007983 Tris buffer Substances 0.000 description 5
- 230000008878 coupling Effects 0.000 description 5
- 238000010168 coupling process Methods 0.000 description 5
- 238000005859 coupling reaction Methods 0.000 description 5
- 230000009260 cross reactivity Effects 0.000 description 5
- 238000000502 dialysis Methods 0.000 description 5
- 238000002347 injection Methods 0.000 description 5
- 239000007924 injection Substances 0.000 description 5
- 230000003902 lesion Effects 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 244000052769 pathogen Species 0.000 description 5
- 241000894007 species Species 0.000 description 5
- 239000002671 adjuvant Substances 0.000 description 4
- 230000000890 antigenic effect Effects 0.000 description 4
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 4
- 238000013461 design Methods 0.000 description 4
- 238000010790 dilution Methods 0.000 description 4
- 239000012895 dilution Substances 0.000 description 4
- 230000000855 fungicidal effect Effects 0.000 description 4
- 239000001963 growth medium Substances 0.000 description 4
- 230000003053 immunization Effects 0.000 description 4
- 238000002649 immunization Methods 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 239000008188 pellet Substances 0.000 description 4
- 230000002829 reductive effect Effects 0.000 description 4
- 238000000926 separation method Methods 0.000 description 4
- 125000006850 spacer group Chemical group 0.000 description 4
- 239000006228 supernatant Substances 0.000 description 4
- 238000011282 treatment Methods 0.000 description 4
- 230000003612 virological effect Effects 0.000 description 4
- QEIFSLUFHRCVQL-UHFFFAOYSA-N (5-bromo-4-chloro-1h-indol-3-yl) hydrogen phosphate;(4-methylphenyl)azanium Chemical compound CC1=CC=C(N)C=C1.C1=C(Br)C(Cl)=C2C(OP(O)(=O)O)=CNC2=C1 QEIFSLUFHRCVQL-UHFFFAOYSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 208000031888 Mycoses Diseases 0.000 description 3
- 239000000020 Nitrocellulose Substances 0.000 description 3
- 235000007238 Secale cereale Nutrition 0.000 description 3
- 229920002684 Sepharose Polymers 0.000 description 3
- 241001533598 Septoria Species 0.000 description 3
- 230000005875 antibody response Effects 0.000 description 3
- 210000000628 antibody-producing cell Anatomy 0.000 description 3
- 238000002820 assay format Methods 0.000 description 3
- 230000001588 bifunctional effect Effects 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- 238000005119 centrifugation Methods 0.000 description 3
- 238000004587 chromatography analysis Methods 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 239000012634 fragment Substances 0.000 description 3
- 244000000004 fungal plant pathogen Species 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 229920001220 nitrocellulos Polymers 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 239000004033 plastic Substances 0.000 description 3
- 229920003023 plastic Polymers 0.000 description 3
- 230000009257 reactivity Effects 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 230000004044 response Effects 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 150000003573 thiols Chemical class 0.000 description 3
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- 208000014770 Foot disease Diseases 0.000 description 2
- 241001149504 Gaeumannomyces Species 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- 239000004743 Polypropylene Substances 0.000 description 2
- 241001361634 Rhizoctonia Species 0.000 description 2
- 241000813090 Rhizoctonia solani Species 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 150000001412 amines Chemical group 0.000 description 2
- 125000003277 amino group Chemical group 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 210000002421 cell wall Anatomy 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 230000021615 conjugation Effects 0.000 description 2
- 210000000172 cytosol Anatomy 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- KAKKHKRHCKCAGH-UHFFFAOYSA-L disodium;(4-nitrophenyl) phosphate;hexahydrate Chemical compound O.O.O.O.O.O.[Na+].[Na+].[O-][N+](=O)C1=CC=C(OP([O-])([O-])=O)C=C1 KAKKHKRHCKCAGH-UHFFFAOYSA-L 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000006167 equilibration buffer Substances 0.000 description 2
- 239000002657 fibrous material Substances 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 230000008014 freezing Effects 0.000 description 2
- 238000007710 freezing Methods 0.000 description 2
- 230000005484 gravity Effects 0.000 description 2
- 230000002209 hydrophobic effect Effects 0.000 description 2
- 230000001900 immune effect Effects 0.000 description 2
- 230000028993 immune response Effects 0.000 description 2
- 210000000987 immune system Anatomy 0.000 description 2
- 230000016784 immunoglobulin production Effects 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 238000002803 maceration Methods 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 239000004570 mortar (masonry) Substances 0.000 description 2
- 238000011587 new zealand white rabbit Methods 0.000 description 2
- FSVCQIDHPKZJSO-UHFFFAOYSA-L nitro blue tetrazolium dichloride Chemical compound [Cl-].[Cl-].COC1=CC(C=2C=C(OC)C(=CC=2)[N+]=2N(N=C(N=2)C=2C=CC=CC=2)C=2C=CC(=CC=2)[N+]([O-])=O)=CC=C1[N+]1=NC(C=2C=CC=CC=2)=NN1C1=CC=C([N+]([O-])=O)C=C1 FSVCQIDHPKZJSO-UHFFFAOYSA-L 0.000 description 2
- JMANVNJQNLATNU-UHFFFAOYSA-N oxalonitrile Chemical compound N#CC#N JMANVNJQNLATNU-UHFFFAOYSA-N 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- KHIWWQKSHDUIBK-UHFFFAOYSA-N periodic acid Chemical compound OI(=O)(=O)=O KHIWWQKSHDUIBK-UHFFFAOYSA-N 0.000 description 2
- 229920001155 polypropylene Polymers 0.000 description 2
- 239000001965 potato dextrose agar Substances 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- NRHMKIHPTBHXPF-TUJRSCDTSA-M sodium cholate Chemical compound [Na+].C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC([O-])=O)C)[C@@]2(C)[C@@H](O)C1 NRHMKIHPTBHXPF-TUJRSCDTSA-M 0.000 description 2
- JQWHASGSAFIOCM-UHFFFAOYSA-M sodium periodate Chemical compound [Na+].[O-]I(=O)(=O)=O JQWHASGSAFIOCM-UHFFFAOYSA-M 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 239000010902 straw Substances 0.000 description 2
- KZNICNPSHKQLFF-UHFFFAOYSA-N succinimide Chemical compound O=C1CCC(=O)N1 KZNICNPSHKQLFF-UHFFFAOYSA-N 0.000 description 2
- 238000010257 thawing Methods 0.000 description 2
- RTKIYNMVFMVABJ-UHFFFAOYSA-L thimerosal Chemical compound [Na+].CC[Hg]SC1=CC=CC=C1C([O-])=O RTKIYNMVFMVABJ-UHFFFAOYSA-L 0.000 description 2
- 238000000108 ultra-filtration Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 239000000080 wetting agent Substances 0.000 description 2
- YMXHPSHLTSZXKH-RVBZMBCESA-N (2,5-dioxopyrrolidin-1-yl) 5-[(3as,4s,6ar)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoate Chemical compound C([C@H]1[C@H]2NC(=O)N[C@H]2CS1)CCCC(=O)ON1C(=O)CCC1=O YMXHPSHLTSZXKH-RVBZMBCESA-N 0.000 description 1
- KHURTEAYLZEQHD-UHFFFAOYSA-N 3-n-propylpropane-1,1,3-triamine Chemical compound CCCNCCC(N)N KHURTEAYLZEQHD-UHFFFAOYSA-N 0.000 description 1
- 235000007319 Avena orientalis Nutrition 0.000 description 1
- 244000075850 Avena orientalis Species 0.000 description 1
- 239000002028 Biomass Substances 0.000 description 1
- 108010017384 Blood Proteins Proteins 0.000 description 1
- 102000004506 Blood Proteins Human genes 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 241000282461 Canis lupus Species 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 241001290235 Ceratobasidium cereale Species 0.000 description 1
- 206010017533 Fungal infection Diseases 0.000 description 1
- 241000221779 Fusarium sambucinum Species 0.000 description 1
- 241001149475 Gaeumannomyces graminis Species 0.000 description 1
- 102000006395 Globulins Human genes 0.000 description 1
- 108010044091 Globulins Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- 108010001336 Horseradish Peroxidase Proteins 0.000 description 1
- 108090001030 Lipoproteins Proteins 0.000 description 1
- 102000004895 Lipoproteins Human genes 0.000 description 1
- 206010029719 Nonspecific reaction Diseases 0.000 description 1
- 244000137852 Petrea volubilis Species 0.000 description 1
- 241000209504 Poaceae Species 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 241000209056 Secale Species 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 101000588258 Taenia solium Paramyosin Proteins 0.000 description 1
- 239000013504 Triton X-100 Substances 0.000 description 1
- 229920004890 Triton X-100 Polymers 0.000 description 1
- 241000251539 Vertebrata <Metazoa> Species 0.000 description 1
- 241001360088 Zymoseptoria tritici Species 0.000 description 1
- ZOIORXHNWRGPMV-UHFFFAOYSA-N acetic acid;zinc Chemical compound [Zn].CC(O)=O.CC(O)=O ZOIORXHNWRGPMV-UHFFFAOYSA-N 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 238000005273 aeration Methods 0.000 description 1
- 125000003172 aldehyde group Chemical group 0.000 description 1
- 150000001299 aldehydes Chemical group 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 150000001408 amides Chemical group 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical class N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- 150000001556 benzimidazoles Chemical class 0.000 description 1
- 230000008033 biological extinction Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 150000001718 carbodiimides Chemical class 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000003593 chromogenic compound Substances 0.000 description 1
- 230000003749 cleanliness Effects 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 230000001268 conjugating effect Effects 0.000 description 1
- 239000012228 culture supernatant Substances 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- ATDGTVJJHBUTRL-UHFFFAOYSA-N cyanogen bromide Chemical compound BrC#N ATDGTVJJHBUTRL-UHFFFAOYSA-N 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000003292 diminished effect Effects 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 239000002158 endotoxin Substances 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 208000010801 foot rot Diseases 0.000 description 1
- 238000004362 fungal culture Methods 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 239000011213 glass-filled polymer Substances 0.000 description 1
- 239000003966 growth inhibitor Substances 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 208000002672 hepatitis B Diseases 0.000 description 1
- NAQMVNRVTILPCV-UHFFFAOYSA-N hexane-1,6-diamine Chemical compound NCCCCCCN NAQMVNRVTILPCV-UHFFFAOYSA-N 0.000 description 1
- 230000003100 immobilizing effect Effects 0.000 description 1
- 230000000984 immunochemical effect Effects 0.000 description 1
- 230000005847 immunogenicity Effects 0.000 description 1
- 238000001114 immunoprecipitation Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 239000002198 insoluble material Substances 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 229920006008 lipopolysaccharide Polymers 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 230000002879 macerating effect Effects 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 239000012092 media component Substances 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000002991 molded plastic Substances 0.000 description 1
- 229940045641 monobasic sodium phosphate Drugs 0.000 description 1
- 229910000403 monosodium phosphate Inorganic materials 0.000 description 1
- 235000019799 monosodium phosphate Nutrition 0.000 description 1
- VMGAPWLDMVPYIA-HIDZBRGKSA-N n'-amino-n-iminomethanimidamide Chemical compound N\N=C\N=N VMGAPWLDMVPYIA-HIDZBRGKSA-N 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- UYDLBVPAAFVANX-UHFFFAOYSA-N octylphenoxy polyethoxyethanol Chemical compound CC(C)(C)CC(C)(C)C1=CC=C(OCCOCCOCCOCCO)C=C1 UYDLBVPAAFVANX-UHFFFAOYSA-N 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 239000006179 pH buffering agent Substances 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 102000013415 peroxidase activity proteins Human genes 0.000 description 1
- 108040007629 peroxidase activity proteins Proteins 0.000 description 1
- 235000020030 perry Nutrition 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- BOLDJAUMGUJJKM-LSDHHAIUSA-N renifolin D Natural products CC(=C)[C@@H]1Cc2c(O)c(O)ccc2[C@H]1CC(=O)c3ccc(O)cc3O BOLDJAUMGUJJKM-LSDHHAIUSA-N 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 229910000033 sodium borohydride Inorganic materials 0.000 description 1
- 239000012279 sodium borohydride Substances 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- BEOOHQFXGBMRKU-UHFFFAOYSA-N sodium cyanoborohydride Chemical compound [Na+].[B-]C#N BEOOHQFXGBMRKU-UHFFFAOYSA-N 0.000 description 1
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 235000011008 sodium phosphates Nutrition 0.000 description 1
- VGTPCRGMBIAPIM-UHFFFAOYSA-M sodium thiocyanate Chemical compound [Na+].[S-]C#N VGTPCRGMBIAPIM-UHFFFAOYSA-M 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 238000011146 sterile filtration Methods 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 229960002317 succinimide Drugs 0.000 description 1
- 239000012134 supernatant fraction Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 125000003831 tetrazolyl group Chemical group 0.000 description 1
- 229940033663 thimerosal Drugs 0.000 description 1
- 125000003396 thiol group Chemical group [H]S* 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- 239000011534 wash buffer Substances 0.000 description 1
- 239000004246 zinc acetate Substances 0.000 description 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B02—CRUSHING, PULVERISING, OR DISINTEGRATING; PREPARATORY TREATMENT OF GRAIN FOR MILLING
- B02C—CRUSHING, PULVERISING, OR DISINTEGRATING IN GENERAL; MILLING GRAIN
- B02C19/00—Other disintegrating devices or methods
- B02C19/08—Pestle and mortar
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/37—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/14—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from fungi, algea or lichens
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56961—Plant cells or fungi
Definitions
- This invention relates to a highly sensitive and specific method for detecting polyvalent antigens in plant tissue.
- it relates to a rapid immunoassay for antigen associated with fungal infection of wheat causing cereal eyespot disease.
- Another aspect of this invention relates to a novel grinding apparatus for extraction of antigens from infected plant tissue.
- Cereal eyespot is a fungal disease of wheat, rye, oats, barley, and grasses.
- the disease is found in many parts of the world with cool, moist climates and is especially prevalent in the Great Lakes and Pacific Northwest regions of the United States and in portions of South America, Europe, New Zealand, Australia, and Africa.
- the disease cycle begins in autumn or early spring when PseudPCerCQSPPrella her p otrichoides spores carried over on field stubble from the previous year's crop are deposited on the basal culm (foot) of the young cereal plants by rain splash.
- the spores germinate and superficially infect outer leaf sheaths.
- Eyespot is the only early season foot disease of wheat that usually warrants the application of fungicide for control. While severe take-all and sharp eyespot outbreaks may result in economically important crop loss, the cost benefit ratio does not usually justify treatment.
- Benzimidazoles and certain sterol-biosynthesis-inhibiting fungicides have been shown to be effective treatments for cereal eyespot. Field data indicate that there is a two to three week application window when fungicide treatment results in maximum disease control. The timing of this narrow application window depends on weather conditions, cereal cultivar, and disease pressure.
- the antibody response to a given antigen is determined genetically and varies between species of animals. Immunoassays are particularly well suited for detection of polyvalent antigens that can complex with two or more antibodies at the same time. One such assay is referred to as a "sandwich” assay since the antigen has two antibodies bound to its surface at different sites. Unlabelled antibody (capture antibody) immobilized on the surface of an insoluble solid support matrix captures the antigen contained within a fluid medium. After suitable incubation, the solid support matrix is washed to remove the fluid sample, including any unreacted antigen, and is then contacted with a solution containing a known quantity of labelled second antibody.
- the second antibody may be "labelled" with a variety of substances including radioisotopes, fluorescent chromophores, or enzymes. During subsequent incubation the labelled second antibody reacts with the antigen fixed to the solid support matrix and in so doing also becomes fixed. The solid support matrix is washed a second time to remove unreacted second antibody. The presence of antigen within the test sample is demonstrated by detection of the bound label.
- An assay based on this technique for detection of the antigen associated with serum hepatitis is described in U.S. Pat. No. 3,867,517, and is referred to as a "forward-sandwich" immunoassay.
- Variations of the assay format exist and include: (1) reaction of the antigen sample with the labelled second antibody before incubation with the immobilized unlabelled antibody (referred to as a "reverse-sandwich” immunoassay), and (2) incubation of antigen with labelled and unlabelled antibody at the same time (“simultaneous-sandwich” immunoassay).
- Reverse-sandwich immunoassay
- immobilized unlabelled antibody referred to as a "reverse-sandwich” immunoassay
- Bolik et al. [Z. convincedkr. Deschutz, 94, 449-456 (1987)] have reported development of an immunoassay for detection of E. herpotrichoides in artificially inoculated wheat stems. Rabbits were immunized with suspensions of freeze-dried mycelia. The resulting polyclonal antibodies were used to develop an immunoassay according to the method of Clark and Adams (supra). The assay detected both wheat and rye isolates of P_. herpotrichoides but cross-reacted with other genera of important wheat pathogens and exhibited nonspecific reactions. Bolik et al. suggest that monoclonal antibodies be used instead of polyclonal reagents to overcome these problems.
- a grinding device comprising a cylindrical tube, one end of the tube being closed with a circular base.
- the base of the tube having on its interior face a plurality of radiating ridges constituting a first grinding surface.
- the grinding device also includes a plunger having a first end and a second end, the first end being cylindrical and having radiating ridges complementary to the ridges of the first grinding surface constituting a second grinding surface.
- the first end of the plunger is slidably insertable into the cylindrical tube and axially rotatable therein.
- the second end of the plunger has a means for rotating the plunger within the cylindrical tube so as to grind material positioned between the first and second grinding surfaces.
- Applicants' invention also includes a method for assaying the fungus Pseudocercosporella. in which a fungal antigen is extracted from plant tissue into an aqueous medium and a reaction system is formed on a solid support by contacting the aqueous medium containing the fungal antigen with a number of components. These components include (1) a high titer polyclonal capture antibody monospecific for the fungal antigen;
- a reporter mechanism The components are combined in proportions such that a signal from the reporter mechanism is related to the presence of, or concentration of, fungal antigen initially present in the aqueous medium.
- the method also includes measuring the signal from the reaction system and relating the signal to the presence or concentration of fungal antigen intitially present in the aqueous medium.
- Applicants* invention further includes a kit for assaying for the Pseudocercosporella antigen in cereal plants.
- the kit includes the grinding device and the components of the assay previously mentioned.
- Figure 1 is a schematic diagram showing components of the Pseudocercosporella assay.
- Figure 2a is a graph demonstrating the relationship between disease severity and Pseudocercosporella immunoassay results using infected wheat plants that were greenhouse grown.
- Figure 2b is a graph demonstrating the sensitivity of the Pseudocercosporella immunoassay using samples of wheat plants infected in the field with ___ herpotrichoides.
- Figure 3 is a bar graph showing the cross-reactivity of a forward sandwich enzyme immunoassay performed on fungal extracts of Septoria. Gaeumannomyces and Fusarium using cross-reactive, polyclonal, rabbit-anti-E ⁇ . herpotrichoides immunoglobulin (Ig) as the capture antibody.
- Figure 4 is a bar graph showing the results of absorbed, monospecific rahh-i -anri-Pseudocercosporella Ig used as capture antibody in a forward sandwich enzyme immunoassay and tested for cross-reactivity against fungal extracts of Septoria. Gaeumannomvces, and Fusarium antigens.
- Figure 5 displays data showing that the assay is sensitive enough to detect picogram quantities of the £. herpotrichoides antigen.
- Figure 6 demonstrates the utility of the tissue grinding apparatus used in conjunction with the Pseudocercosporella immunoassay.
- Figure 7 shows an elevation view of a grinder tube and lid.
- Figure 8 shows the top of the grinder tube base which forms the first grinding surface.
- Figure 9 shows the bottom of the grinder tube base.
- Figure 10 shows an elevation view of the plunger.
- Figure 11 shows the top of the plunger including means for manual or automatic rotation.
- Figure 12 shows the bottom of the plunger which forms the second grinding surface.
- Figure 13 shows a vertical section of the assembled parts of the grinding device.
- Figure 14 shows a vertical section of a preferred embodiment of the grinding device.
- the present invention describes a rapid, sensitive, and specific method for determining the presence and/or concentration of polyvalent and/or multivalent antigenic substances of the fungus p_. herpotrichoides in a sample.
- the method also employs a novel grinding apparatus for extraction of the antigen from plant material.
- Fungal antigen refers to any fungal substance or group of fungal substances which are capable of eliciting an immune response when injected into animals. Fungal antigens are discussed extensively by Longbottom and Austwick in Immunochemistry [ed. by Weir et al., Ch. 7 (1982)].
- immunogenic refers to the intrinsic capacity of an antigen to elicit the production of antibodies when injected into an animal host.
- polyvalent refers to an antigen molecule having different immunogenic sites in response to which antibody molecules are produced.
- multivalent refers to an antigen molecule having multiple occurrences of a single immunogenic site.
- antigenic substances may be mentioned polysaccharides, proteins, nucleic acids, lipids, and any aggregate or regularly ordered structure comprised of multiple or repeating units or combinations of such substances (e.g., glycoproteins, lipopolysaccharides, and lipoproteins) .
- specific fungal antigens which may be assayed by the process of the present invention are components of spores, hyphae, or cytosol including structural components, toxins, enzymes, elicitors, or other pathogenic factors whether they are secreted, extracted, crude, or purified.
- Antibody relates to a blood serum protein of the globulin fraction formed in response to antigen.
- Polyclonal antibody refers to any preparation containing heterogeneous populations of antibody molecules produced by genetically unique, clonally distinct antibody producing cells, whether derived from the serum of an animal or prepared artificially by mixing together different monoclonal antibodies.
- Monoclonal antibody refers to homogeneous preparations of antibody molecules produced by a single population of cloned antibody producing cells.
- Reaction system refers to the assembled components of the immunoassay described herein.
- High titer refers to the capacity of an antiserum to be active at dilutions of 1: 50,000 or greater.
- FIG. 1 shows the components of the immunoassay assembled on a solid support (SS) .
- the capture antibody (C.Ab) is a monospecific polyclonal rabbit-anti-Zj. herpotrichoides antiserum (RAP) Ig that has captured Pseudocercosporella antigen (P.Ag) previously extracted from plant material into a buffer.
- a cross-reactive labelled antibody (L.Ab) is also bound to the Pseudocercosporella antigen (P.Ag) and also serves as the attachment point for a reporter mechanism.
- the avidin-enzyme conjugate (A-E) , biotin (B) , and the enzyme specific substrate (S) are collectively known as the reporter mechanism.
- An avidin-enzyme conjugate (A-E) was attached to the biotin of the labelled antibody (L.Ab).
- a substrate (S) introduced into the reaction system and specific for the enzyme (E) of the avidin-enzyme conjugate (A-E) produced a colored product (CP) which is measured by means of a spectrophotometer.
- CP colored product
- the order in which the components are assembled on the solid support (SS) depends on the conditions under which the assay will be used and the objectives of the assay. Extraction of Fungal Antigens from Plant Tissue As £. herpotrichoides invades plant tissue, antigens are produced by the fungus. These antigens must be extracted from fungal and plant matrices before they can be detected by the assay. A consistent extraction method is required if the assay is to be both sensitive and reproducible. Since the assay may be performed with both young and old plant tissue, as well as with dried straw, an extraction procedure capable of macerating fibrous material is required.
- the present invention describes several ways of extracting fungal antigens from all types of plant materials.
- the two major components of the extraction system are the extraction solvent and the extraction apparatus.
- the solvent may be virtually any aqueous medium. Water alone suffices, however various additives may improve assay performance.
- pH buffering agents such as di- and mono-basic sodium phosphate or tris[hydroxymethyl]- aminomethane (Tris) help maintain neutral pH in the sample and yield more consistent results.
- Tris tris[hydroxymethyl]- aminomethane
- a surfactant or wetting agent such as polyoxyethylene- sorbatan monolaurate (Tween 20), octyl phenoxy polyethoxyethanol (Triton X-100), or sodium dodecyl sulfate aids in the extraction of fungal antigens. It is often desirable to limit microbial growth in the extracted plant material, particularly if the samples are to be stored for any length of time prior to assaying. Including a microbial growth inhibitor such as sodium azide, chloroacetamide or sodium ethylmercurithiosalicylate (thimerosal) is generally sufficient.
- the extraction buffer consists of a Tris buffered s.aline (TBS) or phosphate buffered saline solution (PBS) with azide or chloroacetamide added as a preservative and Tween 20 added as a wetting agent.
- TBS Tris buffered s.aline
- PBS phosphate buffered saline solution
- Extraction of fungal antigens from plant parts may be assisted by means of mechanical maceration of the plant and fungal biomass in the presence of extraction buffer.
- Maceration of soft, decomposed, or very young tissue may be accomplished by any number of techniques, including using Potter or Dounce type glass homogenizers, crushing between two hard surfaces, or repeated freezing and thawing. Older plants and dried straw require more rigorous techniques, such as grinding in a mortar and pestle with or without the assistance of a grinding aid such as sand or powdered glass. These techniques are very labor intensive and do not lend themselves to use outside of the laboratory or to the processing of large numbers of samples.
- the present invention describes a tissue grinding apparatus specifically designed to enhance the extraction of fungal antigens from all types of plant materials.
- a grinding apparatus 10 illustrated in Figures 7 through 14 was designed having three parts: a grinding tube (12), a one- or two-piece plunger (24), and a lid (22).
- the grinding tube (12) is closed at one end by a circular base
- the base (14) also has a central peg (20) that protrudes from the base (14) within the grinding tube (12) and along the tube's longitudinal axis.
- the head (26) of the plunger (24) provides a second grinding surface (28) 0 of radiating ridges (18) that fits into the grinding tube (12) to contact the first grinding surface (16).
- the plunger head (26) may be made as a separate unit from the plunger handle (32) in which case interlocking key (48) prevents the handle (32) 5 and plunger head (26) from rotating independently.
- the second grinding surface (28) is interrupted at its center by a cavity (30) which fits over the grinding tube's peg (20) along the longitudinal axis.
- the plunger (24) is free to u rotate within the grinding tube (12) and extends out from the top of the grinding tube (12) in a handle (32) having features such as grips (34) or a depression (38) to assist either hand (34) or machine (38) rotation.
- the design of the tube (12) and 5 plunger (24) is such that unground tissue sample is held between the grinding surfaces (16) and (28) in grinding zone (40), while macerated tissue is flushed away from the grinding zone (40) by the extraction buffer into the separation zone (42).
- This 0 separation is achieved by providing a restricted clearance space (44) between the inner wall of the tube (12) and the grinding head (26).
- the restricted clearance space (44) is 0.007 of an inch.
- An approximate range for the 5 restricted clearance space is 0.005 to 0.013 inches.
- the design of the grinding surfaces is critical to the consistent performance of this invention. Most designs result in clogging of the grinding surface with plant material, thus greatly reducing grinding efficiency.
- the present invention has grinding surfaces (16 and 28) which do not clog.
- the grinding surfaces (16 and 28) have ridges (18) which extend radially from the center of each grinding surface.
- the ridges (18) on the base (14) of the tube (12) and the plunger grinding head (26) are complimentary.
- the two surfaces interlock and disengage repeatedly when one or both of the two grinding surfaces are rotated about the tube's longitudinal axis.
- the constant engaging/disengaging action causes the grinding surfaces to abrade and crush the plant tissue at their interface.
- previously ground tissue is swept away from the grinding zone (40) by the extraction buffer decreasing the possibility of clogging.
- the peg (20) and cavity (30) in the center of the apparatus (10) excludes plant material from the center of the grinding surfaces (16 and 28) where grinding is less efficient due to reduced rotational motion and the diminished size of ridges (18).
- the peg (20) and cavity (30) mechanism is collectively known as a grind enhancing and alignment means (31) .
- the space labelled (46) between the central peg (20) and the inner wall of the cavity (30) is 0.005 inches.
- An approximate range for this space is 0.003 to 0.010 inches.
- This alignment space (46) is less than the space (44) between the inner wall of the tube and the plunger head.
- Figure 14 illustrates a preferred embodiment of the grinding device.
- the one piece tool/handle in this embodiment eliminates assembly of the tool and enhances reliability and cleanability.
- the grinding surfaces (16 and 28) are not perpendicular to the longitudinal axis of the tube (12). Rather they are at an angle such that extraction buffer and fungal antigens from the macerated plant material flow by gravity to the bottom of the grinding zone (40) and then into the separation zone (42) through the restricted clearance space (44). Further, the angled grinding surface also permits shedding of extraction buffer as the tool is withdrawn from the cup, thus avoiding spillage and enhancing cleanability.
- the angle employed is not critical and can vary from 10° to 45° from the horizontal, preferably between 15° and 25°.
- ribs spaced equally around the plunger (24). The ribs strengthen the plunger and provide a mixing action during grinding.
- the plunger handle (32) in this embodiment has an expanded upper portion (47) that fits closely within the tube (12) such that the plunger can freely rotate.
- the clearance between the expanded upper portion (47) and the tube (12) can correspond to the clearance space (44). This feature helps stabilize the plunger during grinding and prevents materials from splashing out of the tube.
- the expanded upper portion (47) can have a hole (48) for sample removal. If desired, the expanded upper portion can be fitted with a lid and serve as a reservoir for the extraction buffer.
- the grinder (10) may be constructed out of metal, ceramic, glass, or plastic materials. Since the preferred use of the grinder is as an inexpensive, disposable apparatus, injection molded plastics such as polypropylene, polystyrene, polyethylene, or polycarbonate are preferred. The grinder may also be used to macerate other materials such as seeds or soil in which case a harder material such as glass-filled plastic is required.
- the lid (22) in Figure 7 is used to maintain the cleanliness of the tube (12) and to protect the fungal antigen once extracted.
- Antigens derived from £. herpotrichoides may be isolated from the natural environment or cultured in vitro under optimal conditions to enhance the expression of immunogenic and, preferably, diagnostic antigens of the fungus while minimizing the amount of non-specific material in the antigenic extract obtained.
- Culture media may be liquid, solid, synthetic, defined, complex, enriched, or supplemented or combinations of these including tissues or substances derived from or comprised of cereal plants, preferably wheat. Other culture considerations include temperature, light, atmosphere, aeration, length of incubation, and other factors obvious to those skilled in the art.
- Specific antigenic substances may be isolated from live or killed cells.
- Fungal cultures can be conveniently separated into solid and liquid fractions by either filtration or centrifugation.
- Culture filtrates or supernatants may contain metabolites or extracellular fungal antigens. Preparation of these molecules generally requires concentration and specific procedures such as dialysis or ultrafiltration to separate out media components.
- the solid fraction can be further processed by mechanical or physical disruption (e.g., drying and grinding, homogenizing, freezing and thawing and sonicating), extraction with solvents or detergents, or digestion with enzymes, acids, alkali or other chemical means.
- the processed solid fraction can be further divided into cell wall and cytoplasmic (cytosol) fractions as a result of such disruption.
- the antigen may be a spore, hyphae, cytoplasmic fraction, toxin, enzyme, exoantigen, elicitor, polysaccharide, protein, nucleic acid, or any aggregate or regularly ordered structure composed of multiple repeating units or combinations of such structures or substances.
- Fungal antigens may be injected directly into animals capable of making antibodies to that substance.
- the antigens may require further preparation to enhance their immunogenicity prior to injection.
- Such procedures include mixing antigens with an appropriate adjuvant or conjugating antigens to a suitable carrier molecule.
- Factors affecting the immune response to injected antigens include the dose, route, timing, number of injections, genetic constitution of the animal (e.g., species and strain) and physical nature of the antigen (e.g., polysaccharide vs. protein). The choice of these factors for the immunization protocol depends upon the desired characteristics of the resulting antibodies.
- relevant antigens may include extracellular substances such as exoantigens or enzymes, factors involved in the pathogenesis of the disease such as elicitors, or components of the
- the sensitivity of sandwich immunoassays is dependent upon the binding affinity of the antibody for the antigen and the overall avidity or strength by which the antigen is bound to the solid phase.
- Antigens may interact at multiple sites with antibody immobilized on the solid phase. Thus, the strength with which polyvalent or multivalent antigens are bound increases exponentially as a function of the number of valences involved in their attachment.
- polyclonal antibodies immobilized on the solid phase may be expected to bind polyvalent antigens with greater avidity than monoclonal antibodies due to the inherent heterogeneity of the polyclonal reagent. Greater sensitivity can be
- Preparations of polyclonal antibodies can be made more specific by selectively removing those antibody molecules that cross-react. This can be done by immunoabsorption of such preparations with antigens to which the reagent cross-reacts.
- the specificity of polyclonal reagents can also be improved by selectively purifying only those antibody molecules specific for the antigen of interest by means of immunoaffinity chromatography. This method can be time consuming, result in low yields and loss of high affinity antibodies from the population.
- immunoabsorption techniques remove cross-reactive antibodies in a one step process, do not deplete high affinity antibodies, and can result in high yields. As shown in the Examples, Applicants used immunoabsorption techniques to create a monospecific antibody reagent by removing cross-reactive antibodies.
- mice especially the highly inbred strains used for the production of monoclonal antibodies, are highly restricted in their capacity to make antibodies to many antigens, including polysaccharides which are the primary components of the hyphal cell wall. It has been demonstrated that mice produce low titer, low affinity antisera when injected with preparations of fungal antigens. Thus, it may not be possible to isolate monoclonal antibodies with the desired sensitivity and specificity to detect important diagnostic fungal antigens. In contrast, rabbits of the type used routinely for the production of antibody reagents are outbred animals which frequently exhibit strong antibody responses to antigens which mice respond poorly to, including fungal antigens. While the current art champions the potential of monoclonal antibodies to increase the specificity and sensitivity of fungal immunoassays it has failed to realize the limitations of this technology imposed on it by the genetics of the mouse immune system.
- polyclonal antibody reagents offer many advantages over monoclonal reagents.
- the present invention uses an immunoabsorption technique to increase specificity by eliminating the cross-reactivity of rabbit-anti-E ⁇ . herpotrichoides (RAP) polyclonal antiserum to non-Pseudocercosporella antigens.
- RAP herpotrichoides
- immunoglobulin refers to antibody and "monospecific” refers to preparations of Ig that have been rendered specific for Pseudocercosporella by immunoabsorption with cross-reacting fungi. There are a number of ways to prepare immunoabsorbed Ig.
- Available techniques include liquid phase immunoprecipitation with soluble fungal antigens, solid phase immunoabsorption with insoluble fungal components, and solid phase immunoabsorption with fungal antigen-solid support matrix conjugates. Each of these techniques involve treating the RAP Ig preparation with antigens prepared from cross-reacting fungi in order to specifically bind and remove cross-reactive antibodies. Fungi which may be used to immunoabsorb a RAP Ig reagent include Septoria tritici,
- Covalently attaching an antigen, including its derivatives and analogs, to a solid support depends upon the particular molecular architecture of both types of molecules.
- Antigens contain functional groups such as amines, amides, carboxyls, sulfhydryls, hydroxyls, and/or aldehydes to which a support matrix with its own appropriate functional groups could be attached directly or indirectly.
- the attachment chemistry may vary depending upon the functional groups involved and the desirability of including a spacer arm between the antigen and the solid support. The resulting matrix must retain the ability to react with antibody.
- carbohydrate could be attached to agarose through a spacer arm, such as 1,6-diaminohexane, diaminodipropylamine, or other bifunctional crosslinking agents after periodate oxidation.
- a spacer arm can enhance the immunochemical reactivity of the conjugate.
- crosslinking agents both homo- and hetero- bifunctional, have been described in the literature and are available commercially [Pierce Bio-Research Products Technical Bulletin, "Double-Agents", Bifunctional Crosslinking Reagents, Vol.3 Pierce Chemical Co., Rockford, IL, U.S.A., 1982].
- These crosslinking agents can be used in conjunction with many different linkage strategies, depending on which functional groups are available for conjugation on both the antigen and solid support.
- Carbodiimide crosslinking agents such as l-ethyl-3-(3-dimethylaminopropyl)carbodiimide, can also be employed to link antigens with carboxyl groups to amino groups on amino-activated agarose or conversely, to link the amino groups of the antigen to carboxyl groups on carboxyl-activated agarose.
- support matrices may be purchased from commercial suppliers which have been pre-treated with crosslinking reagents. These "activated" supports will react directly with antigen functional groups when mixed in the appropriate coupling buffers. Examples of-activated agarose support matrices and the functional groups to which they react are listed in Table 1.
- matrix means any antigen molecule attached, directly or indirectly, to a solid support.
- the assay to detect £. herpotrichoides antigen in infected plant tissue may be configured in numerous formats. All formats require immobilization of antigen or capture antibody onto a solid support.
- the solid support matrices may be microtiter plates, tubes, beads, magnetic particles, membranes and other well known supports.
- immobilized antigen the plant extract is adsorbed directly to the solid support and then reacted with a labelled antibody specific for fungal antigen. Since both plant material and fungal antigen adsorb to the support, the fungal antigen density on the solid support is limited by the presence of non-specific plant material. This usually results in low assay sensitivity. It is important to detect the presence of £. herpotrichoides in wheat stems before the expression of symptoms. Therefore, it is desirable to have an assay with high sensitivity.
- the use of immobilized capture antibody in a forward-sandwich assay as schematically shown in Figure 1 is understood to be more sensitive than reverse or simultaneous sandwich assays.
- the capture antibody (C.Ab) is adsorbed to the solid support (SS) and then reacted with plant extract.
- the capture antibody (C.Ab) serves to selectively immobilize the fungal antigen (P.Ag) from the plant extract and results in a high specific antigen density on the solid support.
- the bound fungal antigen (P.Ag) is then reacted with a labelled second antibody (L.Ab).
- immunoreagent may be used to perform the assay. Generally, purified Ig reagents improve assay performance. Assay specificity is achieved by the use of immunoabsorbed reagents.
- the capture antibody, second antibody, or both, may be immunoabsorbed. Using the capture antibody as the only immunoabsorbed reagent may result in slightly improved assay sensitivity over other configurations.
- reporter mechanism used to indicate the presence of bound antigen includes radioisotopes, fluorescent chromophores, chromophoric particles and enzymes. Enzymes are preferred due to the availability of sensitive chromogenic substrates and the availability of simple instrumentation to quantitate results.
- the use of horseradish peroxidase may be limited due to the presence of endogenous peroxidase activity in plant and fungal extracts which can result in high non-specific color development.
- Alkaline phosphatase is the preferred label and its use results in low nonspecific color development and excellent assay sensitivity.
- the applicants used the soluble yellow color signal produced by the enzyme substrate p-nitrophenyl phosphate and measured the signal as described in Examples lg, Ih, li and 2.
- 5-bromo-4-chloro-3-indolyl phosphate, p-toluidine salt may be used in conjuction with a tetrazolium salt, such as nitroblue tetrazolium chloride, to yield an insoluble formazan dye precipitate.
- the color signal is related to the presence or concentration of fungal antigen initially present in the aqueous medium.
- the reporter mechanism may be prepared using several techniques.
- the first technique requires the use of chemical conjugation methods similar to those described in the "Antigen Support Matrix Immunoabsorbant" section above.
- the result is an immunoglobulin molecule covalently coupled to one or more label molecules.
- immunoglobulin and the label may be coupled via non-covalent techniques, such as with the use of a streptavidin-biotin system or the avidin-biotin system as taught in U.S. Patent No. 4,228,237.
- kit format for their invention permits convenient, fast testing in the field of cereal crops suspected of being infected with the Pseudocercosporella fungus.
- the kit will include the grinding device and the preparations of the various assay components described herein.
- Culture flasks containing 100 ml of sterile Potato Dextrose Broth (Difco, Detroit, MI) were inoculated with the spores and hyphae from one of the following fungi: £. herpotrichoides. £. tritici. £. rosew ⁇ / £• solani. or £. graminis. Cultures were shaken at 100 rpm for one to two weeks at 23°. Following the incubation period, hyphae and culture supernatants were separated by centrifugation at 3000xg for 10 min and stored frozen at -20°.
- Fungal antigens were then prepared by sodium cholate extraction of the spent culture media and macerated hyphae.
- Culture medium was added to hyphal pellets to result in a hyphal suspension of approximately 1 ml of media per 1 ml of packed hyphae.
- the hyphal suspensions were adjusted to 0.1% sodium cholate by the addition of a 1% stock solution in PBS (20 mM sodium phosphate, 140 mM sodium chloride) containing 0.05% sodium azide (PBS/azide) .
- the hyphae were thoroughly homogenized in Dounce-type tissue grinders. Homogenates were centrifuged at 3000xg for 10 min at 4° and the resulting cell pellets were discarded.
- the supernatant fractions were combined with the remainder of the spent culture media and the mixtures were dialyzed exhaustively against two changes of saline (140 mM sodium chloride) followed by a final buffer change into coupling buffer (100 mM sodium bicarbonate, 500 mM sodium chloride, pH 8.5) using-dialysis membranes with an 8,000 MW cutoff.
- the dialyzed extracts were concentrated to approximately 10 ml by ultra-filtration in stirred-cells (Amicon, Bedford, MA) using 10,000 MW cut-off membrane filters.
- a first immunogen was prepared by culturing four isolates of £. herpotrichoides. including wheat, rye and Pacific Northwest strains in Potato Dextrose Broth (Difco) . The cultures were homogenized and fungal fragments counted using a microscope and hemacytometer. All four strains were diluted in PBS and pooled to yield a mixture containing approximately equal numbers of fragments of each of the four strains. The pooled mixture (4 x 10 5 fungal fragments per ml) was emulsified with an equal volume of either complete Freund's adjuvant (CFA) or incomplete Freund's adjuvant (IFA) prior to injection into the animals. Three New Zealand white rabbits were given two 1 ml injections of the fungal-adjuvant emulsion subcutaneously (SC) at multiple sites on days 0 (CFA) and 24 (IFA) .
- CFA complete Freund's adjuvant
- IFA incomplete Freund's adjuvant
- a second antigen was prepared by grinding into powder the lyophilized hyphae of £. herpotrichoides (a wheat strain) grown in mineral dextrose yeast (MDY) broth. The powdered hyphae (1 gram) was resuspended in 10 ml PBS and centrifuged to pellet insoluble material. The clarified supernatant (optical density at 280 nm « 4.9) was sterilized by filtration through a 0.45 um membrane (Gelman, Ann Arbor, MI) and used to immunize previously injected New Zealand white rabbits.
- Each rabbit was injected with 0.5 ml antigen B intravenously (IV) and 0.5 ml emulsified with 0.5 ml IFA intramuscularly (IM) on day 81.
- Antiserum was harvested from rabbits bled on days 0, 39, 49, 88, 91 and 95.
- a third immunogen (C) was prepared from a wheat strain fungal extract (Example la) . The concentrated extract was centrifuged at 7800xg for 20 min and the supernatant sterile filtered. The sterile supernatant was emulsified with an equal volume of IFA and injected on days 140 and 168 (0.5 ml IM and 1.0 ml SC) . Antisera were harvested from rabbits bled on days 154, 182 and 187.
- RAP Ig Rabbit-anti- P. herpotrichoides Immunoglobulin
- Purified RAP Ig was prepared from pooled antisera harvested from two of the rabbits bled on days 182 and 187. Fifty-five ml of antisera were filter sterilized, mixed with an equal volume of saturated ammonium sulfate and incubated 1 h at 4°. The precipitated Ig was harvested by centrifugation, dissolved in a small volume of saline and dialyzed in 14,000 MW cutoff dialysis tubing 48 h in two changes of PBS at 4° (2 liters each change).
- the dialyzed Ig solution was centrifuged at 3000xg for 20 min to remove precipitated material.
- a Protein A Sepharose 4B slurry (32 ml, Pharmacia, Piscataway, NJ) was poured into a column (2.5 x 20 cm) and equilibrated with 300 ml 3 M NaCl, 1.0 M Glycine, pH 8.8 (U.S. Patent No. 4,704,366).
- the clarified Ig solution was mixed with an equal volume of equilibration buffer and allowed to pass through the column at a rate determined by gravity (approx. 1 ml/min) .
- the column was washed with equilibration buffer until the absorbance at 280 nm reached the baseline.
- Antibody was eluted from the column with 53 ml of 0.1 M sodium citrate, pH 3.0 and dialyzed overnight at 4° in two changes of PBS (4 liters each change) .
- the concentration of purified Ig was determined using an extinction coefficient E(l%, 280 nm)-14.3.
- E-XAMPLE le Preparation of Biotinylated Rabbit-anti- P. herpotrichoides Immunoglobulin Conjugate Purified RAP Ig (100 mg, 5 mg/ml PBS) was diluted with an equal volume of 0.1 M bicarbonate buffer pH 8.1. The diluted Ig was dialyzed with 14,000 MW cutoff dialysis tubing for 24 h at 4° in two changes of 6 liters 0.1 M bicarbonate buffer.
- N-Hydroxy-succinimidobiotin (Pierce, Rockford, IL) was dissolved in dimethyl sulfoxide (5 mg/ml) and 4.2 ml reacted with the dialyzed Ig (40 ml) for 4 h at room temperature.
- the resulting conjugate solution was dialyzed against two changes of PBS (6 liters each change) for 96 h at 4°.
- the biotin-Ig conjugate was prepared for storage at 4° by addition of bovine serum albumin (1% final concentration), glycerol (10% v/v), sodium azide (0.1%) and sterile filtration.
- the cross-reactive Ig was removed by a solid phase immunoabsorption technique to yield monospecific RAP Ig.
- Fungal extracts from Example la of £. tritici. £. roseum. R. cerealis. and £. graminis were coupled separately to cyanogen bromide-activated Sepharose 4B (Pharmacia AB, Laboratory Separation Division, Uppsala, Sweden).
- cyanogen bromide-activated Sepharose 4B Pharmacia AB, Laboratory Separation Division, Uppsala, Sweden.
- HC1 hydrochloric acid
- the gel was rapidly filtered down to a moist paste, transferred to a polypropylene centrifuge tube, resuspended into 1 gel bed volume of coupling buffer, and centrifuged at 500 x g for two minutes.
- the gel pellet was saved and immediately combined with approximately 10 ml of fungal extract.
- the antigens were allowed to react with the activated gel matrix for 2.5 h at room temperature for Seotoria. Fusarium. and Gaeumannomvces or overnight at 4° for Rhizoctonia. with gentle mixing under both conditions. Following incubation, the gel was washed twice with 1 ml of coupling buffer. Remaining reactive groups on the Septpria, Fusarium.
- Figure 4 is a bar graph showing the results of absorbed monospecific RAP Ig used as capture antibody in a forward sandwich enzyme immunoassay and demonstrating cross-reactivity to fungal extracts of Septoria. Fusarium, and GaeumannPmyceg antigens.
- EXAMPLE g Pseudocercosporella Immunoassay The Pseudocercosporella Immunoassay on plant tissue suspected of being infected with £. herpotrichoides was performed. The format consisted of a 96 well microtiter plate. The general assay protocol, consisted of 50 ul reagent additions per well, 1 h reagent incubations at 25° followed by four washes with 10 mM Tris, pH 7.4, 140 mM sodium chloride, 0.05% sodium azide, 0.05% Tween 20 (TBS/Tween) .
- RAP Ig cross-reactive or monospecific
- 10 mM bicarbonate coating buffer pH 9.6
- Samples were diluted in TBS/Tween and incubated with antibody coated wells. After the plates were incubated and washed, biotin-conjugated RAP Ig diluted to approximately 10 ug/ml in TBS/Tween was applied to the wells.
- Figures 2a and 2b illustrate the sensitivity of the Pseudocercosporella Immunoassay for detecting the presence of £. herpotrichoides infection before the appearance of symptoms in both greenhouse- ( Figure 2a) and field- ( Figure 2b) infected wheat stems. Samples were prepared according to Example lb.
- Figures 3 and 4 illustrate the specificity of the Pseudpcercpspprella Immunoassay for £. herpotrichoides when monospecific RAP Ig is used to coat the surface of microtiter plates. Wells were coated with unabsorbed (Figure 3) or monospecific ( Figure 4) RAP Ig and reacted with fungal extracts described in Example la of £. tritici. £. ⁇ QS ⁇ UIQ, £. herpptrichPJfles, and G_. graminis diluted 1:100 in TBS/Tween.
- Figure 5 shows that the assay is sensitive enough to detect picogram quantities of £. herpotrichoides antigen. The concentration of £.
- herpotrichoides antigen was determined by dialyzing a wheat strain fungal extract, against PBS as in Example lb, evaporating a 0.5 ml sample to dryness at 37° , determining the weight of the dried residue and calculating the weight of the £. herpotrichoides antigen by subtracting out the weight of the salt.
- the general assay protocol following procedures described in Example lg, consisted of 100 ⁇ l reagent additions per well, 30 min reagent incubations at 25° followed bythree washes with 10 mM Tris, pH 7.4, 140 mM sodium chloride, 0.04% chloroacetamide, and 0.05% Tween 20 (TBSC/Tween).
- Monospecific RAP Ig was diluted to approximately 10 ⁇ g/ml in 0.1 M bicarbonate coating buffer at pH 9.6 and added to microtiter plate wells. Samples were diluted in TBSC/Tween and incubated with antibody coated wells.
- biotin-conjugated RAP Ig diluted to approximately 5 ⁇ g/ml in TBSC/Tween was applied to the wells.
- Final reagent additions consisted of streptavidin-alkaline phosphatase conjugate diluted to approximately 1 ⁇ g/ml in TBSC/Tween followed by p-nitrophenyl phosphate substrate solution (Kirkegaard and Perry Laboratories, Inc.). Color development in the wells was measured spectrophotometrically at 405 nm.
- EXAMPLE li Membrane Format Pseudocercosporella Immunoassay Membrane based immunoassays were performed in a Fast-ChekTM device (E-Y Labs, Inc., San Mateo, CA) .
- the device consists of a porous nitrocellulose membrane backed with several pieces of absorbant paper encased within a plastic body. The surface of the nitrocellulose membrane serves as the solid support for immobilizing the capture antibody. Reagents applied to the surface of the solid support wick through the pores of the membrane into the absorbant paper backing. Reagents and buffers were identical to those described in Example li except where noted.
- alkaline phosphatase substrate 5-bromo-4-chloro-3-indolyl phosphate, p-toluidine salt was used in conjunction with nitroblue tetrazolium chloride (BCIP/NBT Phosphatase Substrate, Kirkegaard and Perry Labs, Inc.) to yield an insoluble blue precipitate on the membrane.
- BCIP/NBT Phosphatase Substrate Kirkegaard and Perry Labs, Inc.
- the assay was performed in accordance with the Examples la, and lc through lh.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Hematology (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Genetics & Genomics (AREA)
- Urology & Nephrology (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biotechnology (AREA)
- Virology (AREA)
- Botany (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Gastroenterology & Hepatology (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Un système d'analyse immunométrique spécifique, sensible et rapide est présenté pour déterminer la présence et/ou la concentration d'antigènes associés à l'infection des céréales pour l'agent pathogène fongique Pseudocercosporella herpotrichoides. Il comprend un appareillage de broyage pour extraire de tels antigènes dans un milieu liquide adapté. Un réactif antigène, monospécifique, polyclonal est utilisé dans une analyse immunologique de type "en sandwich à l'avant" pour la détection des antigènes fongiques polyvalents associés au développement de la maladie cercosporellose des céréales.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US39826589A | 1989-08-24 | 1989-08-24 | |
US398265 | 1989-08-24 |
Publications (1)
Publication Number | Publication Date |
---|---|
EP0534963A1 true EP0534963A1 (fr) | 1993-04-07 |
Family
ID=23574702
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP19900914368 Withdrawn EP0534963A1 (fr) | 1989-08-24 | 1990-08-16 | Analyse immunologique pour detecter et determiner l'antigene de pseudocercosporellose dans les cereales |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP0534963A1 (fr) |
AU (1) | AU6417990A (fr) |
WO (1) | WO1991002590A2 (fr) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9018689D0 (en) * | 1990-08-24 | 1990-10-10 | Dow Chemical Co | Antigenic material,antibodies raised thereto,hybridomas for producing antibodies,and immunoassays incorporating such antibodies |
DE4391002T1 (de) * | 1992-03-06 | 1995-02-23 | Rambus Inc | Vor-heranholen in einen Cache-Speicher zum minimieren der Hauptspeicherzugriffszeit und der Cache-Speichergröße in einen Computersystem |
US5355391A (en) * | 1992-03-06 | 1994-10-11 | Rambus, Inc. | High speed bus system |
DE4390991T1 (de) * | 1992-03-06 | 1995-02-23 | Rambus Inc | Verfahren und Schaltungsanordnung zum Minimieren der Takt-Daten-Schieflage in einem Bussystem |
USRE39879E1 (en) * | 1992-03-06 | 2007-10-09 | Rambus, Inc. | Method of transferring data by transmitting lower order and upper order memory address bits in separate words with respective op codes and start information |
US5715407A (en) * | 1992-03-06 | 1998-02-03 | Rambus, Inc. | Process and apparatus for collision detection on a parallel bus by monitoring a first line of the bus during even bus cycles for indications of overlapping packets |
US5485490A (en) * | 1992-05-28 | 1996-01-16 | Rambus, Inc. | Method and circuitry for clock synchronization |
US5268639A (en) * | 1992-06-05 | 1993-12-07 | Rambus, Inc. | Testing timing parameters of high speed integrated circuit devices |
JP3279681B2 (ja) * | 1992-09-03 | 2002-04-30 | 株式会社日立製作所 | 半導体装置 |
US5558996A (en) * | 1994-07-01 | 1996-09-24 | Strategic Diagnostics Inc. | Fungus extraction method, kit, and extraction solution |
US20040241662A1 (en) * | 2003-05-30 | 2004-12-02 | Robey W. Wade | Detecting microbial contamination in grain and related products |
IE20030856A1 (en) * | 2003-11-14 | 2005-06-15 | Enfer Technology Ltd | Sample homogeniser |
CN113777064B (zh) * | 2021-09-10 | 2022-04-01 | 合肥工业大学 | 一种炭角菌胞内多糖体外抗氧化活性检测试剂盒及其检测方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4366930A (en) * | 1981-04-27 | 1983-01-04 | Trombetti Jr Albert V | Tablet pulverizer |
US4765549A (en) * | 1986-05-15 | 1988-08-23 | Renee Sherman | Tablet pulverizer |
DE3690785T1 (de) * | 1986-10-13 | 1989-03-23 | Willaume Jantzen Erik | Reibmuehle zum vermahlen von gewuerzen |
-
1990
- 1990-08-16 EP EP19900914368 patent/EP0534963A1/fr not_active Withdrawn
- 1990-08-16 WO PCT/US1990/004506 patent/WO1991002590A2/fr not_active Application Discontinuation
- 1990-08-16 AU AU64179/90A patent/AU6417990A/en not_active Abandoned
Non-Patent Citations (1)
Title |
---|
See references of WO9102590A2 * |
Also Published As
Publication number | Publication date |
---|---|
WO1991002590A2 (fr) | 1991-03-07 |
AU6417990A (en) | 1991-04-03 |
WO1991002590A3 (fr) | 1992-04-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6342389B1 (en) | Modified phycobilisomes and uses therefore | |
JP3202772B2 (ja) | ヘリコバクターピロリ検出用の抗原調製物 | |
Sundstrom et al. | Characterization of antigens specific to the surface of germ tubes of Candida albicans by immunofluorescence | |
US3966898A (en) | Method and reagent for determining immunologic materials | |
EP0534963A1 (fr) | Analyse immunologique pour detecter et determiner l'antigene de pseudocercosporellose dans les cereales | |
US6362008B1 (en) | Generic signalling mechanism for detection of analytes | |
Mohan | Evaluation of antisera raised against Phytophthora fragariae for detecting the red core disease of strawberries by enzyme‐linked immunosorbent assay (ELISA) | |
CA1121723A (fr) | Antigenes l thermostables de neisseria gonorrhea dont on a purifie les proteines et les glucides | |
Cooper et al. | Discoidin-binding polysaccharide from Dictyostelium discoideum. | |
US4351761A (en) | Purified antigen to test for Neisseria gonorrhoeae antibodies | |
Etzler et al. | Subcellular localizations of two Dolichos biflorus lectins | |
Scheffer et al. | Detection of a phytotoxic glycopeptide produced by Ophiostoma ulmi in elm by enzyme-linked immunospecific assay (ELISA) | |
JP3739319B2 (ja) | トリコテセン系マイコトキシンの検出方法及びその試薬 | |
EP0555418A1 (fr) | Methodes de dosage faisant appel a une liaison competitive entre un peptide et des antigenes de complexe majeur d'histocompatibilite | |
Amouzou-Alladaye et al. | Immunoenzymatic detection of Phytophthora fragariae in infected strawberry plants. | |
KR20050026396A (ko) | Bt-cry 독소의 고속 검출법 | |
KR19980703763A (ko) | 피코빌리좀, 유도체 및 이의 용도 | |
DeVay et al. | The tissue and cellular location of a major cross-reactive antigen shared by cotton and soil-borne fungal parasites | |
Reeves et al. | Characterization and evaluation of a soluble antigen complex prepared from the yeast phase of Histoplasma capsulatum | |
Pfister et al. | Seroepidemiologic studies of bovine papillomavirus infections | |
JPH10502254A (ja) | 真菌抽出方法及びキット | |
Cowan | Effect of Merthiolate on agar gel diffusion precipitin reactions with foot-and-mouth disease virus | |
SU1673973A1 (ru) | Способ диагностики заболеваний растений, вызванных РSеUDомоNаS SYRINGae 1у серогруппы | |
JP2007527523A (ja) | 飼料用酵素を検出するための試薬、方法、及びキット | |
Cameron et al. | An enzyme-linked procedure for the detection and estimation of surface receptors on cells |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 19920224 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK FR GB LI SE |
|
17Q | First examination report despatched |
Effective date: 19931021 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 19940301 |